BWA
AMPH icon

Basecamp Wealth Advisors’s Amphastar Pharmaceuticals AMPH Stock Holding History

Basecamp Wealth Advisors’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$89.1K Buy
4,416
+60
+1% +$1.21K 0.02% 415
2026
Q1 		$85.3K Sell
4,356
-32
-0.7% -$783 0.02% 425
2025
Q4 		$118K Buy
+4,388
New +$113K 0.03% 347

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Basecamp Wealth Advisors's AMPH Position: Q2 2026 in Review

Basecamp Wealth Advisors increased its Amphastar Pharmaceuticals (AMPH) stake by 1.4% in Q2 2026, buying an estimated $1.21K and bringing the position to 4,416 shares worth $89.1K. The position accounts for 0.02% of the portfolio, ranked #415.

Basecamp Wealth Advisors first reported a position in AMPH in Q4 2025 and has held it in 3 quarters since. The position peaked at $118K in Q4 2025. 210 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.

  • Basecamp Wealth Advisors held 4,416 shares of Amphastar Pharmaceuticals worth $89.1K as of Q2 2026.
  • Basecamp Wealth Advisors bought 60 Amphastar Pharmaceuticals shares in Q2 2026, an estimated $1.21K.
  • Amphastar Pharmaceuticals made up 0.02% of Basecamp Wealth Advisors's portfolio in Q2 2026, its #415 holding.
  • Basecamp Wealth Advisors first reported a position in Amphastar Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Basecamp Wealth Advisors's Amphastar Pharmaceuticals position peaked at $118K in Q4 2025.
  • 210 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.

Based on Basecamp Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.